Company Filing History:
3 out of 25 
3 out of 321 
Years Active: 2006-2011
Title: **Ha Ryoung Poo: Pioneering Innovations in Vaccine Development**
Introduction
Ha Ryoung Poo is an innovative inventor based in Daejeon, South Korea. With a strong focus on biotechnology, he has successfully developed significant inventions, earning a total of three patents to date.
Latest Patents
Among his notable contributions, Ha Ryoung Poo's latest patents include a vector for an anti-HPV vaccine and a transformed microorganism that utilizes this vector. These expression vectors are designed to efficiently produce virion capsid proteins and tumor-associated proteins of human papillomavirus on a microbial surface. The bacterial strains that harbor such surface display vectors are outlined, along with methods for preparing these vectors, vaccines, and transformed microorganisms. The surface display vectors integrate one or more than two genes chosen from pgsB, pgsC, and pgsA, which encode a poly-γ-glutamic acid synthetase complex (pgsBCA) of the asp. strain, in addition to genes that encode virion capsid proteins and tumor-associated proteins.
Career Highlights
Ha Ryoung Poo has made a mark in his field through his innovative approach and dedication. He has worked with prominent institutions such as Bioleaders Corporation and the Korea Research Institute of Bioscience and Biotechnology, where he contributed to pivotal research in vaccine development and microbial biotechnology.
Collaborations
Throughout his career, Ha Ryoung Poo has collaborated with esteemed colleagues, including Moon-Hee Sung and Chul-Joong Kim. These partnerships reflect his commitment to advancing scientific research and developing effective solutions in the realm of health and immunology.
Conclusion
Ha Ryoung Poo's pioneering work in the development of an anti-HPV vaccine and the associated microbial technologies underscore the profound impact of his innovations in the biomedical field. His contributions not only enhance the understanding of vaccine production but also pave the way for future advancements in combating viral diseases.